Quality measures and benchmarking for warfarin therapy

Phillips KW, Ansell J (2008) Outpatient management of oral vitamin K antagonist therapy: defining and measuring high-quality management. Expert Rev Cardiovasc Ther 6:57–70 The Joint Commission (2011) National Patient Safety Goals. http://www.jointcommission.org/assets/1/18/July_2010_NPSGs_Scoring_HAP2.pdf Wallentin L, Yusuf S, Ezekowitz MD et al (2010) Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial. Lancet 376:975–983 White HD, Gruber M, Feyzi J et al (2007) Comparison of outcomes among patients randomized to warfarin therapy according to anticoagulant control: results from SPORTIF III and V. Arch Intern Med 167:239–245 Veeger NJ, Piersma-Wichers M, Tijssen JG, Hillege HL, van der Meer J (2005) Individual time within target range in patients treated with vitamin K antagonists: main determinant of quality of anticoagulation and predictor of clinical outcome. A retrospective study of 2300 consecutive patients with venous thromboembolism. Br J Haematol 128:513–519 Cannegieter SC, Rosendaal FR, Wintzen AR et al (1995) Optimal oral anticoagulant therapy in patients with mechanical heart valves. N Engl J Med 333:11–17 Brook RH, McGlynn EA, Cleary PD (1996) Quality of health care. Part 2: measuring quality of care. N Engl J Med 335:966–970 Rose AJ, Berlowitz DR, Frayne SM, Hylek EM (2009) Measuring quality of oral anticoagulation care: extending quality measurement to a new field. Jt Comm J Qual Patient Saf 35:146–155 Arnason T, Wells PS, van Walraven C, Forster AJ (2006) Accuracy of coding for possible warfarin complications in hospital discharge abstracts. Thromb Res 118:253–262 Fang MC, Go AS, Chang Y et al (2007) Death and disability from warfarin-associated intracranial and extracranial hemorrhages. Am J Med 120:700–705 van Walraven C, Oake N, Coyle D, Taljaard M, Forster AJ (2009) Changes in surrogate outcomes can be translated into clinical outcomes using a Monte Carlo model. J Clin Epidemiol 62:1306–1315 Connolly SJ, Pogue J, Eikelboom J et al (2008) Benefit of oral anticoagulant over antiplatelet therapy in atrial fibrillation depends on the quality of international normalized ratio control achieved by centers and countries as measured by time in therapeutic range. Circulation 118:2029–2037 Jones M, McEwan P, Morgan CL et al (2005) Evaluation of the pattern of treatment, level of anticoagulation control, and outcome of treatment with warfarin in patients with non-valvar atrial fibrillation: a record linkage study in a large British population. Heart 91:472–477 Morgan CL, McEwan P, Tukiendorf A et al (2009) Warfarin treatment in patients with atrial fibrillation: observing outcomes associated with varying levels of INR control. Thromb Res 124:37–41 Wilson SJ, Wells PS, Kovacs MJ et al (2003) Comparing the quality of oral anticoagulant management by anticoagulation clinics and by family physicians: a randomized controlled trial. CMAJ 169:293–298 Rosendaal FR, Cannegieter SC, van der Meer FJ, Briet E (1993) A method to determine the optimal intensity of oral anticoagulant therapy. Thromb Haemost 69:236–239 Fihn SD, McDonell M, Martin D et al (1993) Risk factors for complications of chronic anticoagulation. A multicenter study. Warfarin Optimized Outpatient Follow-up Study Group. Ann Intern Med 118:511–520 Fihn SD, Callahan CM, Martin DC et al (1996) The risk for and severity of bleeding complications in elderly patients treated with warfarin. The National Consortium of Anticoagulation Clinics. Ann Intern Med 124:970–979 van Walraven C, Oake N, Wells PS, Forster AJ (2007) Burden of potentially avoidable anticoagulant-associated hemorrhagic and thromboembolic events in the elderly. Chest 131:1508–1515 Clark NP, Witt DM, Delate T et al (2008) Thromboembolic consequences of subtherapeutic anticoagulation in patients stabilized on warfarin therapy: the low INR study. Pharmacotherapy 28:960–967 Crowther MA, Ageno W, Garcia D et al (2009) Oral vitamin K versus placebo to correct excessive anticoagulation in patients receiving warfarin: a randomized trial. Ann Intern Med 150:293–300 Dentali F, Riva N, Malato A et al (2009) Incidence of thromboembolic complications in patients with mechanical heart valves with a subtherapeutic international normalized ratio. J Thorac Cardiovasc Surg 137:91–93 Asnis PD, Gardner MJ, Ranawat A et al (2007) The effectiveness of warfarin dosing from a nomogram compared with house staff dosing. J Arthroplasty 22:213–218 Doecke CJ, Cosh DG, Gallus AS (1991) Standardised initial warfarin treatment: evaluation of initial treatment response and maintenance dose prediction by randomised trial, and risk factors for an excessive warfarin response. Aust NZ J Med 21:319–324 Kovacs MJ, Cruickshank M, Wells PS et al (1998) Randomized assessment of a warfarin nomogram for initial oral anticoagulation after venous thromboembolic disease. Haemostasis 28:62–69 Lazo-Langner A, Monkman K, Kovacs MJ (2009) Predicting warfarin maintenance dose in patients with venous thromboembolism based on the response to a standardized warfarin initiation nomogram. J Thromb Haemost 7:1276–1283 Monkman K, Lazo-Langner A, Kovacs MJ (2009) A 10 mg warfarin initiation nomogram is safe and effective in outpatients starting oral anticoagulant therapy for venous thromboembolism. Thromb Res 124:275–280 Poller L, Keown M, Ibrahim S et al (2008) An international multicenter randomized study of computer-assisted oral anticoagulant dosage vs. medical staff dosage. J Thromb Haemost 6:935–943 Ageno W, Turpie AG (1998) A randomized comparison of a computer-based dosing program with a manual system to monitor oral anticoagulant therapy. Thromb Res 91:237–240 Manotti C, Moia M, Palareti G et al (2001) Effect of computer-aided management on the quality of treatment in anticoagulated patients: a prospective, randomized, multicenter trial of APROAT (Automated PRogram for Oral Anticoagulant Treatment). Haematologica 86:1060–1070 Marco F, Sedano C, Bermudez A et al (2003) A prospective controlled study of a computer-assisted acenocoumarol dosage program. Pathophysiol Haemost Thromb 33:59–63 Mitra R, Marciello MA, Brain C, Ahangar B, Burke DT (2005) Efficacy of computer-aided dosing of warfarin among patients in a rehabilitation hospital. Am J Phys Med Rehabil 84:423–427 (1998) Guidelines on oral anticoagulation: third edition. Br J Haematol 101:374–387 Ansell J, Hirsh J, Hylek E et al (2008) Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition). Chest 133:160S–198S Walter LC, Davidowitz NP, Heineken PA, Covinsky KE (2004) Pitfalls of converting practice guidelines into quality measures: lessons learned from a VA performance measure. JAMA 291:2466–2470 HEDIS and Quality Measurement (2011) http://www.ncqa.org/tabid/59/Default.aspx